Evidence map›Paper›PMID 36980287›Full record

ReviewCells2023

Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology.

Sophie Combaluzier, Julie Quessada, Norman Abbou, Robin Arcani, Antoine Tichadou, Jean Gabert, Régis Costello, Marie Loosveld, Geoffroy Venton, Yaël Berda-Haddad

Open access · goldFull text readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sophie CombaluzierHematology Laboratory, Timone University Hospital, 13005 Marseille, France.ORCID 0000-0002-4768-2817
Julie QuessadaHematological Cytogenetics Laboratory, Timone University Hospital, 13005 Marseille, France.ORCID 0000-0002-3219-3172
Norman AbbouMolecular Biology Laboratory, North University Hospital, 13015 Marseille, France.
Robin ArcaniINSERM, INRAE, C2VN, Luminy Campus, Aix-Marseille University, 13005 Marseille, France.
Antoine TichadouHematology and Cellular Therapy Department, Conception University Hospital, 13005 Marseille, France.ORCID 0000-0002-1114-6385
Jean GabertMolecular Biology Laboratory, North University Hospital, 13015 Marseille, France.
Régis CostelloINSERM, INRAE, C2VN, Luminy Campus, Aix-Marseille University, 13005 Marseille, France.
Marie LoosveldHematology Laboratory, Timone University Hospital, 13005 Marseille, France.
Geoffroy VentonINSERM, INRAE, C2VN, Luminy Campus, Aix-Marseille University, 13005 Marseille, France.
Yaël Berda-HaddadHematology Laboratory, Timone University Hospital, 13005 Marseille, France.ORCID 0000-0001-7204-0309
Inserm · FRCentre National de la Recherche Scientifique · FRHôpital de la Conception · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell-derived disorders characterized by uncontrolled proliferation of differentiated myeloid cells. Two main groups of MPN,

Indexed as

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMyeloproliferative DisordersPolycythemia VeraHumansMolecular BiologyMutationcytomorphologylaboratory practicemolecular biologymyeloproliferative neoplasms

Identifiers

PMID36980287
PMCPMC10047531
OpenAlexW4328050090

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read75
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.